Shanxi Shuangyan Pharmaceutical Co .,Ltd.

Shanxi Shuangyan Pharmaceutical Co., Ltd. was founded in 2004, with a registered capital of 200million yuan, total assets of 1.6 billion yuan, and more than 1,000 employees. The company is located in the production base of Pharmaceutical Industrial Park of Datong Economic & Technological Development Zone, which mainly produces APIs and oral solid preparation. Our main products are colloidal bismuth pectin, colloidal bismuth tartrate and other preparation of digestive system. Scientific and technological innovation is the driving force for the sustainable development of our company. We have carried out in-depth cooperation with a number of scientific research institutions and achieved a number of research results. At present, we have 10 self-developed products (new drug certificates), 8 national invention patents, and 124 approvals for various types of APIs and FDFs. All manufacturing lines have passed the new GMP certification. The company has been recognized as a "high-tech enterprise" for many years, passed the official audit of the U.S. FDA in 2019, and at the same time won the certification of a number of high-end foreign markets. In 2020, the technology center was evaluated as a "provincial-level technology center in Shanxi Province". Shuangyan has always adhered to the spirit of "pioneering and innovative, striving to surpass, vitality to bear, details to win", to enhance the research and development and innovation ability, to improve product quality, to enrich the product structure, to extend the sales network system, to tap the potential of the market, and to promote the development of the market, and ultimately to build a comprehensive pharmaceutical enterprise with international competitiveness.